S2C6:Clinical Trial Statistics

原文始发于微信公众号(化学音乐文化):S2C6:Clinical Trial Statistics

S2C6:Clinical Trial Statistics

JanFourman,PhD, EdD,MBA, MSRA

S2C6:Clinical Trial Statistics

Eli Lilly – Pharma registration for diabetes/endocrine, women/men’s health, neural science, oncology, bone/muscle/joint therapeutic areas – 5 years
Eli Lilly – Pharmacovigilance – 7 years
Eli Lilly – Regulatory Intelligence – 3 Years
Purdue University and Roche Diagnostics – Teaching global pharma development, Africa and US
Consultant for Indiana Technical Assistance Program
Invited conference speaker
Published author

S2C6:Clinical Trial Statistics
S2C6:Clinical Trial Statistics


Clinical Trial Statistics

Utilizing Statistical Concepts to Make Key Decisions when Designing Clinical Trials:

Introduce clinical trial statistics and their relevance to designing trials

Understand terminology

identify information to compute a sample size

understand how statistical tests are selected

Emphasize the importance of an ongoing collaboration between the statistician and the physician


打赏 为好文打赏 支持药时代 共创新未来! 为好文打赏 支持药时代 共创新未来!
上一篇 2020年2月18日 12:21
下一篇 2020年2月18日 12:29